西点药业
(301130)
| 流通市值：13.79亿 | | | 总市值：17.87亿 |
| 流通股本：5901.74万 | | | 总股本：7649.47万 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 149,449,725.71 | 101,427,291.82 | 55,925,260.77 | 234,840,419.16 |
| 营业总成本 | 151,452,829.88 | 97,477,784.53 | 48,180,633.12 | 222,490,004.98 |
| 其他经营收益 | | | | |
| 营业利润 | 4,070,506.23 | 8,086,404.94 | 9,790,780.82 | 20,220,762.41 |
| 利润总额 | 3,992,044.51 | 8,030,556.3 | 9,963,428.72 | 20,996,168.44 |
| 净利润 | 5,022,716.06 | 7,822,214.56 | 8,602,728.43 | 19,898,052.57 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 5,022,716.06 | 7,822,214.56 | 8,602,728.43 | 19,898,052.57 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 334,303,320.75 | 333,900,035.91 | 330,140,522.36 | 342,861,833.03 |
| 非流动资产: | | | | |
| 非流动资产合计 | 726,008,961.37 | 731,443,709.45 | 717,241,473.53 | 718,717,971.9 |
| 资产总计 | 1,060,312,282.12 | 1,065,343,745.36 | 1,047,381,995.89 | 1,061,579,804.93 |
| 流动负债: | | | | |
| 流动负债合计 | 96,302,317.37 | 100,275,140.31 | 69,854,579.96 | 88,421,168.44 |
| 非流动负债: | | | | |
| 非流动负债合计 | 66,267,072.8 | 64,298,935.68 | 65,302,205.28 | 38,377,482.69 |
| 负债合计 | 162,569,390.17 | 164,574,075.99 | 135,156,785.24 | 126,798,651.13 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 868,690,420.93 | 871,364,856.6 | 882,297,477.9 | 904,271,319.66 |
| 股东权益合计 | 897,742,891.95 | 900,769,669.37 | 912,225,210.65 | 934,781,153.8 |
| 负债和股东权益合计 | 1,060,312,282.12 | 1,065,343,745.36 | 1,047,381,995.89 | 1,061,579,804.93 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 182,961,164.86 | 122,739,900.99 | 65,715,022.18 | 276,284,023.98 |
| 经营活动现金流出小计 | 139,766,797.17 | 95,025,414.03 | 50,753,935.29 | 227,662,778.42 |
| 经营活动产生的现金流量净额 | 43,194,367.69 | 27,714,486.96 | 14,961,086.89 | 48,621,245.56 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 360,844,331.03 | 320,587,670.76 | 217,092,009.3 | 956,777,408.74 |
| 投资活动现金流出小计 | 341,682,195.97 | 251,564,662.5 | 214,416,962.9 | 1,142,421,936.52 |
| 投资活动产生的现金流量净额 | 19,162,135.06 | 69,023,008.26 | 2,675,046.4 | -185,644,527.78 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 41,258,325.2 | 30,725,000 | 30,125,000 | 11,530,000 |
| 筹资活动现金流出小计 | 54,871,017.89 | 44,606,617.41 | 33,258,493.19 | 35,676,332.55 |
| 筹资活动产生的现金流量净额 | -13,612,692.69 | -13,881,617.41 | -3,133,493.19 | -24,146,332.55 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 48,743,810.06 | 82,855,877.81 | 14,502,640.1 | -161,169,614.77 |
| 期末现金及现金等价物余额 | 77,691,589.21 | 111,803,656.96 | 43,450,419.25 | 28,947,779.15 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 82,855,877.81 | - | -161,169,614.77 |